|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/62 | |
| A61K 38/46 | |||
| A61K 47/48 | |||
| A61P 19/08 | |||
| C12N 9/16 |
| (11) | Patento numeris | 1759001 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05739065.0 |
| Europos patento paraiškos padavimo data | 2005-04-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-03-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-04-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2005/000615 |
| Data | 2005-04-21 |
| (87) | Numeris | WO 2005/103263 |
| Data | 2005-11-03 |
| (30) | Numeris | Data | Šalis |
| 563828 P | 2004-04-21 | US | |
| 590347 P | 2004-07-23 | US | |
| 614984 P | 2004-10-04 | US |
| (72) |
CRINE, Philippe, CA
BOILEAU, Guy, CA
LEMIRE, Isabelle, CA
LOISEL, Thomas, P., CA
|
| (73) |
Enobia Pharma Inc.,
2901, rue Rachel Est Suite 23, Montréal, Québec H1W 4A4,
CA
|
| (54) | BONE DELIVERY CONJUGATES AND METHOD OF USING SAME TO TARGET PROTEINS TO BONE |
| BONE DELIVERY CONJUGATES AND METHOD OF USING SAME TO TARGET PROTEINS TO BONE |